Optinose to Present at the Cantor Virtual Global Healthcare Conference
Optinose (NASDAQ:OPTN) has announced that CEO Peter Miller will present a company overview and update at the Cantor Virtual Global Healthcare Conference on September 28, 2021, at 8:40 a.m. ET. Interested parties can access the live webcast on the Investors page of the Optinose website, with a replay available for 30 days post-event. The company specializes in providing solutions for patients treated by ENT and allergy specialists.
- None.
- None.
YARDLEY, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Cantor Virtual Global Healthcare Conference on September 28, 2021, at 8:40 a.m. ET.
To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.
A replay of the webcast will be available for 30 days following the conclusion of the event.
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
FAQ
When is the Optinose presentation at the Cantor Virtual Global Healthcare Conference?
How can I access the Optinose presentation webcast?
Is there a replay available for the Optinose presentation?
What is the focus of Optinose as a pharmaceutical company?
Who is presenting at the Cantor Virtual Global Healthcare Conference for Optinose?
